Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-24-001394

CEO, CFO, Director acquired 1,309 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Finley John David CEO, CFO, Director 2024-01-03 Option exercise +1,309 64,649 D
Derivatives
Finley John David CEO, CFO, Director 2024-01-03 Option exercise · Restricted Stock Units −1,309 0 D
Loading xslF345X05/ownership.xml…